Difference between revisions of "Team:SDU-Denmark/Tour70"

Line 20: Line 20:
 
    
 
    
 
<p>
 
<p>
<span class="intro">However, the challenges and laminations do not stop us</span>, the peptide aptamer produced with our constructs have a broad range of opportunities. Besides challenging the antibodies used in science, they also show promises in a medical aspect. We have discussed some of these aspects in Medical Aspect.  
+
<span class="intro">However, the challenges and laminations do not stop us</span>, the peptide aptamer produced with our constructs have a broad range of opportunities. Besides challenging the antibodies used in science, they also show promises in a medical aspect. We have discussed some of these aspects in <a href="https://2015.igem.org/Team:SDU-Denmark/Tour72">Medical Aspect</a>.  
 
</p>
 
</p>
 
    
 
    
 
<p>
 
<p>
<span class="intro">What the future bring no one can tell</span>, but hopefully PAST is going to be a part of it. The end.
+
<span class="intro">What the future bring no one can tell</span>, but hopefully PAST is going to be a part of it. <a href="https://2015.igem.org/Team:SDU-Denmark/Tour74">The end</a>.
 
</p>
 
</p>
 
</html>
 
</html>
  
 
{{:Team:SDU-Denmark/core/footer}}
 
{{:Team:SDU-Denmark/core/footer}}

Revision as of 10:30, 18 September 2015

"Don't cry because it's over, smile because it happened.” ― Dr. Seuss

What is next?

Not all good thing has to end. We present this year iGEM project at the Giant Jamboree in Boston the 24th -28th of September, but this does not mean the work on the project has to stop. We have been working in a strict time frame, but has there not been any time limit, our project could likely have moved mountains.

Despite of all our efforts in the lab, in the community, on the wiki and everything else there came along, still a lot of aspect remains unexplored. We have been thinking and discussed future work on the project that could take it to the next level. A lot of the future work would be in the wet lab, in aim to examine the peptide aptamer, determine some of its parameter such as its affinity towards its target and its specificity. To read more about our idea for future laboratory work, please go to Lab Work.

To know ones limitation can be beneficial, because first then, one can be able to challenge and push the limit. Working with living organisms provides many challenges and put up some boundaries for what is possible, we are aware of these in our project. To read more about these please go to Challenges and Limitation.

However, the challenges and laminations do not stop us, the peptide aptamer produced with our constructs have a broad range of opportunities. Besides challenging the antibodies used in science, they also show promises in a medical aspect. We have discussed some of these aspects in Medical Aspect.

What the future bring no one can tell, but hopefully PAST is going to be a part of it. The end.